Healthy People 2010 Focus Area 4: Chronic Kidney Disease Progress Review September 21, 2006
4-1. End-stage renal disease 4-2. Cardiovascular disease deaths in persons with chronic kidney failure 4-3. Counseling for chronic kidney failure care 4-4. Use of arteriovenous fistulas 4-5. Registration for kidney transplantation 4-6. Waiting time for kidney transplantation 4-7. End-stage renal disease due to diabetes 4-8a. Medical evaluation for persons with type 1 or type 2 diabetes and chronic kidney disease 4-8b. Medical treatment for persons with type 1 or type 2 diabetes and chronic kidney disease Status of Chronic Kidney Disease Objectives ImprovingGetting worseBaseline data onlyTarget met
End-stage Renal Disease, By Race/Hispanic Origin Obj. 4-1 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Asian Incidence rate per 1,000,000population Target TotalWhite Black Hispanic American Indian ,200 1,
End-stage Renal Disease Due to Diabetes, By Race/Hispanic Origin Obj. 4-7 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Asian Incidence rate per 1,000,000population Target Total White Black Hispanic American Indian ,200 1,
Asian Total White Black Hispanic American Indian ,200 1, ESRD and ESRD Due to Diabetes, By Race/Hispanic Origin Incidence rate per million ,200 1, Asian 2010 Target Total Black Hispanic American Indian 200 White Obj. 4-1 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Obj. 4-7 End-stage Renal Disease Due to Diabetes 2010 Target
End-stage Renal Disease, By Race and Gender Incidence rate per 1,000,000 Obj. 4-1 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. SOURCE: United States Renal Data System (USRDS), NIH, NIDDK. Men Women Asian American Indian Black White Asian American Indian Black White 1,2001, Target
End-stage Renal Disease, By Health Service Area, 1993 Incidence rate per 1,000,000 population Obj. 4-1 SOURCE: United States Renal Data System (USRDS), NIH, NIDDK.
End-stage Renal Disease, By Health Service Area, 2003 Incidence rate per 1,000,000 population Obj. 4-1 SOURCE: United States Renal Data System (USRDS), NIH, NIDDK.
Males End-stage Renal Disease Due to Diabetes, By Gender Incidence rate per 1,000,000population 2010 Target Total Females Obj. 4-7 SOURCE: United States Renal Data System (USRDS), NIH, NIDDK
Asian Use of Arteriovenous Fistulas* Among the Newly Diagnosed By Race/Hispanic Origin Percent Target Total White Black Hispanic American Indian Obj. 4-4 Note: American Indian includes Alaska Native. Asian includes Pacific Islander. The categories black and white exclude persons of Hispanic origin. Persons of Hispanic origin may be any race. SOURCE: Centers for Medicare and Medicaid Services (CMS) Clinical Performace Measures (CPM) project
Females Use of Arteriovenous Fistulas Among the Newly Diagnosed By Gender Percent Target Total Males Obj. 4-4 SOURCE: Centers for Medicare and Medicaid Services (CMS) Clinical Performance Measures (CPM) project
Percent 2010 Target Obj. 4-8a Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. Only one race category could be recorded. Recording more than one race was not an option. SOURCE: Centers for Medicare and Medicaid Services (CMS); United States Renal Data System (USRDS), NIH, NIDDK. Asian White Black Hispanic American Indian Medical Evaluation for Persons with Diabetes and Chronic Kidney Disease
Percent 2010 Target Obj. 4-8a Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. Only one race category could be recorded. Recording more than one race was not an option. SOURCE: Centers for Medicare and Medicaid Services (CMS); United States Renal Data System (USRDS), NIH, NIDDK. Asian White Black Hispanic American Indian Medical Evaluation for Persons with Diabetes and Chronic Kidney Disease Medical evaluation include eye examinations, lipid testing, and glycosylated hemoglobin (HbA1c) testing
0 Percent 2010 Target 4020 Total Hispanic Asian Obj. 4-8b American Indian Black White Native Hawaiian Medical Treatment for Persons with Diabetes and Chronic Kidney Disease Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: USRDS. * 3010 * * * 2000
0 Percent 2010 Target 4020 Total Hispanic Asian Obj. 4-8b American Indian Black White Native Hawaiian Medical Treatment for Persons with Diabetes and Chronic Kidney Disease Note: American Indian includes Alaska Native; Native Hawaiian includes other Pacific Islander. Persons of Hispanic origin may be any race. SOURCE: USRDS. * 3010 * * * Medical treatment includes the use of angiotensin converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) 2000
Progress review data and slides are available on the web at: